Literature DB >> 3733499

Characterization of the subclinical phase of ehrlichiosis in dogs.

E C Codner, L L Farris-Smith.   

Abstract

Prevalence of subclinical Ehrlichia canis infection in a Mississippi kennel was 53%. Most of the dogs probably had been infected for 4 or 5 years. The subclinical phase of the infection was characterized by high antibody titers to E canis (9 of 10 dogs with titers of 1:5, 120), hyperglobulinemia (9 of 10 dogs), thrombocytopenia (5 of 10), absolute lymphocytosis (4 of 10), and absolute neutropenia (3 of 10). The dogs had normal PCV, serum albumin concentrations, and urine protein excretion. Findings indicated that a high percentage of dogs in an enzootic area may develop subclinical ehrlichiosis that may last several years. Despite persistent antigenic stimulation, dogs subclinically infected for a prolonged time did not develop clinically apparent glomerular disease. However, evaluating dogs for antibody titers against E canis is recommended in endemic areas because subclinically infected dogs eventually may develop severe chronic disease, which may be less responsive to therapy.

Entities:  

Mesh:

Year:  1986        PMID: 3733499

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  18 in total

Review 1.  Recent advances in determining the pathogenesis of canine monocytic ehrlichiosis.

Authors:  S Harrus; T Waner; H Bark; F Jongejan; A W Cornelissen
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Efficacy of a doxycycline treatment regimen initiated during three different phases of experimental ehrlichiosis.

Authors:  Jennifer C McClure; Michelle L Crothers; John J Schaefer; Patrick D Stanley; Glen R Needham; S A Ewing; Roger W Stich
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

3.  B-cell lymphoma in a dog with ehrlichiosis (Ehrlichia canis) and systemic histoplasmosis (Histoplasma capsulatum).

Authors:  Jill D Brunker; John P Hoover
Journal:  Can Vet J       Date:  2007-03       Impact factor: 1.008

4.  Molecular and antigenic comparison of Ehrlichia canis isolates from dogs, ticks, and a human in Venezuela.

Authors:  A Unver; M Perez; N Orellana; H Huang; Y Rikihisa
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  Serodetection of Ehrlichia canis infection in dogs from Ludhiana district of Punjab, India.

Authors:  L D Singla; Harkirat Singh; P Kaur; N D Singh; N K Singh; P D Juyal
Journal:  J Parasit Dis       Date:  2011-08-02

6.  Transcriptional analysis of p30 major outer membrane multigene family of Ehrlichia canis in dogs, ticks, and cell culture at different temperatures.

Authors:  A Unver; N Ohashi; T Tajima; R W Stich; D Grover; Y Rikihisa
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  Kinetics of antibody response to Ehrlichia canis immunoreactive proteins.

Authors:  Jere W McBride; Richard E Corstvet; Steven D Gaunt; Charles Boudreaux; Thaya Guedry; David H Walker
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

8.  Cloning and characterization of multigenes encoding the immunodominant 30-kilodalton major outer membrane proteins of Ehrlichia canis and application of the recombinant protein for serodiagnosis.

Authors:  N Ohashi; A Unver; N Zhi; Y Rikihisa
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Reisolation of Ehrlichia canis from blood and tissues of dogs after doxycycline treatment.

Authors:  Z Iqbal; Y Rikihisa
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.